Novo Nordisk’s test drug outperforms rival Lilly’s in diabetic patients
HQ Team September 21, 2026: Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team September 21, 2026: Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic.
HQ Team September 21, 2026: The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to.
HQ Team September 21, 2026: Australia’s Telix Pharmaceuticals will buy ITM Isotope Technologies Munich SE for an upfront payment of $1.65 billion on.
HQ Team September 14, 2026: The death toll from the Ebola virus, which is sweeping through the heart of the Central African region.
HQ Team September 11, 2026: A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a.
HQ Team August 21, 2026: The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization,.
HQ Team August 20, 2026: Nearly 7% of deaths among U.S. flight attendants and pilots are linked to radiation-related cancers — the highest.
HQ Team August 19, 2026: In conflict-ridden Gaza, just 3% of cropland remains usable to grow food as Israeli troops pound the region.
HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo.
HQ Team August 18, 2026: A malaria drug candidate developed by a University of Dundee lab has cleared an early human trial, raising.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)